Hostname: page-component-857557d7f7-cmjwd Total loading time: 0 Render date: 2025-12-11T20:52:17.982Z Has data issue: false hasContentIssue false
  • English
  • Français

Toxoplasmosis and pregnancy

Part of: Bespoke shallow archive Weizmann

Published online by Cambridge University Press:  15 January 2010

TG Overton ,
D Rajasingam  and
PR Bennett
TG Overton*
Affiliation:
Postgraduate Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London.
D Rajasingam
Affiliation:
Postgraduate Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London.
PR Bennett
Affiliation:
Postgraduate Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London.
*
Dr TG Overton, Postgraduate Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, Goldhawk Road, London W6 OXG
Get access Rights & Permissions [Opens in a new window]

Extract

Toxoplasmosis is one of the commonest protozoal infections in man. The causative organism, Toxoplasma gondi has been estimated to have infected in the region of 25–50% of the world's population with evidence of serological infection ranging from 2 to 90% depending on the geographical area. The infection is usually harmless and subclinical, the primary infection being rarely diagnosed. However, it can lead to life threatening disease in the immunocompromised patient and a primary infection in pregnancy can have severe sequelae in the fetus.

Information

Type
Research Article
Information
Fetal and Maternal Medicine Review , Volume 8 , Issue 1 , February 1996 , pp. 11 - 18
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1Joss, AW, Chatterton, JM, Ho-Yen, DO. Congenital Toxoplasmosis: to screen or not to screen? Public Health 1990; 104: 9–20.CrossRefGoogle ScholarPubMed
2Remington, JS and Desmonts, J. In: Remington, JS, Klein, JO eds, Infectious diseases of the fetus and newborn infant 3rd ed. Philadelphia WB Saunders Company, 1990: 90–95.Google Scholar
3Frenkel, JK, Dubey, JP. Toxoplasmosis and its prevention in cats and man. Journal of Infectious Diseases 1972; 126: 664–73.CrossRefGoogle ScholarPubMed
4Stray-Pederson, B. Toxoplasmosis in pregnancy. Baillieres Clinical Obstetrics and Gynaecology 1992; 7: 107–37.CrossRefGoogle Scholar
5Hurley, R, Fever and Infectious Diseases. In: de Swiet, M. ed, Medical Disorders in Obstetric Practice 3rd ed. London: Blackwell Science, 1994; 552–67.Google Scholar
6Ryan, M, Hall, SM, Barrett, NJ, Balfour, AH, Holliman, RE, Joynson, DHM. Toxoplasmosis in England and Wales 1981 to 1992. Communicable Diseases Report Review 1995; 5: 13–20.Google ScholarPubMed
7Mitchel, CD, Erlich, SE, Mastrucci, MT, Hutto, SC, Parks, WP, Scott, GB. Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus I Pediatr Inf Dis J 1990; 9: 512–18.CrossRefGoogle Scholar
8Giovangrandi, Y, Weiner, CP, Smoleniec, J, Brettes, JP. Fetal infection. In: DK, James et al eds, High risk pregnancy; management options London: WB Saunders Company, 1993: 841.Google Scholar
9Wilson, CB, Remington, JS. What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 1980; 138: 357.CrossRefGoogle ScholarPubMed
10Monif, GRG, Torch, Syndrome. 1993: The Parthenon Publishing Group 18–29.Google Scholar
11Sabin, A, Feldman, HA. Dyes as microchemical indicators of new immunity phenomenon affecting protozoan parasite. Science 1948; 108: 660–63.CrossRefGoogle Scholar
12Cazenave, J, Forestier, F, Bessieres, MH, Broussin, B, Begueret, J. Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diagn 1992; 12: 119–27.CrossRefGoogle Scholar
13Foulon, W, Naessens, A, Mahler, T, de Waele, M, de Catte, L.de Meuter, F. Prenatal diagnosis of congenital toxoplasmosis. Obstet Gynecol 1990; 76: 769–72.CrossRefGoogle ScholarPubMed
14Hohlfeld, P, MacAleese, J, Capella-Pavlovsky, M. Fetal toxoplasmosis ultrasonographic signs. Ultrasound in Obstetrics and Gynaecology 1991; 1: 241–4.CrossRefGoogle ScholarPubMed
15Peckham, C, Hall, S, Patel, N, et al. Prenatal screening for toxoplasmosis in the UK 1992 Royal College of Obstetricians and Gynaecologists.Google Scholar
16Jeannel, D, Costagliola, D, Niel, G, Hubert, BDanis, M. What is known about the prevention of congenital toxoplasmosis? Lancet 1990; 336: 359–61.CrossRefGoogle ScholarPubMed
17Rawal, BD. Toxoplasmosis; a dye-test survey on sera from vegetarians and meat eaters in Bombay. Trans R Soc Trop Med Hyg 1959; 53: 61.CrossRefGoogle ScholarPubMed
18Foulon, W, Naessens, A, Lauwers, S, De Meuter, F.Amy, JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynaecol 1988; 72: 363–66.Google ScholarPubMed
19Foulon, W, Naessens, ADerde, MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatology 1994; 11: 57–62.Google Scholar
20Henderson, JB, Beattie, CP, Hale, EJ, Wright, J. The evaluation of new services: possibilities for preventing congenital toxoplasmosis. Int J Epidemiol 1984; 13: 65–72.Google Scholar
21McCabe, R and Remington, JS. Toxoplasmosis: the time has come. N Eng J Med 1988; 318: 313–15.CrossRefGoogle ScholarPubMed
22Daffos, F, Forestier, F, Capella-Pavlovsky, M. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Eng J Med 1988; 318: 271–75.CrossRefGoogle ScholarPubMed
23Rolland, M.Sarramon, MF et al. Termination of pregnancy for maternal toxoplasmosis. Lancet 1994; 344: 36–39.Google Scholar